Xilio Therapeutics Competitors and Similar CompaniesClear all

Xilio Therapeutics's competitors and similar companies include Kite Pharma, RAPT Therapeutics and Alligator Bioscience.

	Xilio Therapeutics Xilio Therapeutics (formerly Akrevia Therapeutics) is a biopharmaceutical company focused on developing targeted immuno-oncology therapeutics.	Kite Pharma Kite Pharma is a company developing cancer immunotherapy products based on cell therapy.	RAPT Therapeutics RAPT Therapeutics (also known as FLX Bio) is a biopharmaceutical company that develops and commercializes immuno-oncology agents.	Alligator Bioscience Alligator develops antibody-based pharmaceuticals for cancer treatment.
Founding Date	Founding Date 2015	Founding Date 2009	Founding Date 2015	Founding Date 2001
Type	Type Public	Type Subsidiary	Type Public	Type Public
Tags	Tags Healthcare biotech drug development oncology pharma therapy	Tags Healthcare biotech drug development oncology pharma therapy	Tags Healthcare biotech drug development oncology pharma therapy	Tags Healthcare biotech drug development oncology pharma therapy
Locations	Locations Waltham, US HQ	Locations Santa Monica, US HQ Hoofddorp, NL London, GB El Segundo, US Emeryville, US Frederick, US Oceanside, US see more	Locations South San Francisco, US HQ	Locations Lund, SE HQ
Employees	Employees 69	Employees 3,9671% decrease	Employees 64	Employees 1555% decrease
Valuation ($)	Valuation ($) 43.5 m	Valuation ($) N/A	Valuation ($) 69.8 m	Valuation ($) 59 m
Financial
Revenue (est.)	Revenue (est.) $43.8m (FY, 2025)	Revenue (est.) N/A	Revenue (est.) N/A	Revenue (est.) kr514k (FY, 2025)
Net income	Net income ($35m) (FY, 2025)	Net income N/A	Net income ($129.9m) (FY, 2024)	Net income (kr51.4m) (FY, 2025)
Funding
Total funding raised	Total funding raised $ 233m	Total funding raised $ 85.3m	Total funding raised $ 176m	Total funding raised N/A